Authors:
GIANOTTI L
FORTIS C
BRAGA M
GENTILINI O
VIGNALI A
DICARLO V
Citation: L. Gianotti et al., RADICAL ONCOLOGIC SURGERY AFFECTS THE CIRCULATORY LEVELS OF INTERLEUKIN-10, Journal of surgical oncology, 66(4), 1997, pp. 244-247
Citation: M. Maffezzini et al., SALVAGE IMMUNOTHERAPY WITH SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 (RIL-2) AND ALPHA-INTERFERON (A-IFN) FOR STAGE D3 PROSTATE CARCINOMA FAILING 2ND-LINE HORMONAL TREATMENT, The Prostate, 28(5), 1996, pp. 282-286
Authors:
CAPELLI E
BARNI S
VACCARONE R
FORTIS C
NANO R
Citation: E. Capelli et al., CELL ACTIVATION AND DEATH (APOPTOSIS) INDUCED BY IL-2 - ULTRASTRUCTURAL EVIDENCE, Anticancer research, 16(4A), 1996, pp. 1775-1780
Authors:
BRAGA M
GIANOTTI L
GENTILINI O
FORTIS C
CONSOGNO G
DICARLO V
Citation: M. Braga et al., THYMOPENTIN MODULATES TH1 AND TH2 CYTOKINE RESPONSE AND HOST SURVIVALIN EXPERIMENTAL INJURY, The Journal of surgical research, 62(2), 1996, pp. 197-200
Authors:
CITTERIO G
PELLEGATTA F
DILUCCA G
FRAGASSO G
SCAGLIETTI U
PINI D
FORTIS C
TRESOLDI M
RUGARLI C
Citation: G. Citterio et al., PLASMA NITRATE PLUS NITRITE CHANGES DURING CONTINUOUS INTRAVENOUS-INFUSION INTERLEUKIN-2, British Journal of Cancer, 74(8), 1996, pp. 1297-1301
Authors:
FORTIS C
GALLI L
CONSOGNO G
CITTERIO G
MATTEUCCI P
SCAGLIETTI U
BUCCI E
Citation: C. Fortis et al., SERUM LEVELS OF SOLUBLE CELL-ADHESION MOLECULES (ICAM-1, VCAM-1, E-SELECTIN) AND OF CYTOKINE TNF-ALPHA INCREASE DURING INTERLEUKIN-2 THERAPY, Clinical immunology and immunopathology, 76(2), 1995, pp. 142-147
Authors:
BRAGA M
DIFRANCESCO A
GIANOTTI L
VIGNALI A
COSTANTINI E
SOCCI C
FORTIS C
PAGANELLI G
DICARLO V
Citation: M. Braga et al., THYMOPENTIN INCREASES THE SURVIVAL OF MICE AFTER ALLOGENEIC BLOOD-TRANSFUSION, BACTERIAL GAVAGE, AND BURN INJURY, The European journal of surgery, 160(6-7), 1994, pp. 345-350
Authors:
BESANA C
BORRI A
BUCCI E
CITTERIO G
DILUCCA G
FORTIS C
MATTEUCCI P
TOGNELLA S
TRESOLDI M
BAIOCCHI C
LANDONIO G
GHISLANDI E
RUGARLI C
Citation: C. Besana et al., TREATMENT OF ADVANCED RENAL-CELL CANCER WITH SEQUENTIAL INTRAVENOUS RECOMBINANT INTERLEUKIN-2 AND SUBCUTANEOUS ALPHA-INTERFERON, European journal of cancer, 30A(9), 1994, pp. 1292-1298
Authors:
CLEMENTI E
BUCCI E
CITTERIO G
LANDONIO G
CONSOGNO G
FORTIS C
Citation: E. Clementi et al., REVERSIBLE ANERGY IN CIRCULATING LYMPHOCYTES OF CANCER-PATIENTS DURING INTERLEUKIN-2 THERAPY, Cancer immunology and immunotherapy, 39(3), 1994, pp. 167-171
Authors:
MATTEUCCI P
TRESOLDI M
CHIESA G
TOGNELLA S
CITTERIO G
FORTIS C
BESANA C
RUGARLI C
Citation: P. Matteucci et al., INTRAPLEURAL ADMINISTRATION OF INTERLEUKIN-2 AND LAK CELLS IN LOCALLYADVANCED NON-SMALL-CELL LUNG-CANCER - A CASE-REPORT, Tumori, 80(3), 1994, pp. 246-250
Citation: C. Fortis, ROLE OF INTERLEUKIN-2 IN REGULATING LYMPHOCYTE-ACTIVATION AND RECIRCULATION (VOL 29A, PG 474, 1993), European journal of cancer, 29A(7), 1993, pp. 1074-1074